Sramek Insight

Our Mission

2022

We encourage breakthrough therapies and diagnostic tests, driven by medical AI and to create new methods of prevention and treatment for cardiovascular diseases.

Our Leadership Team

Our team combined with technology experts, data scientists and professionals in medical and healthcare sector, to guide our mission and to develop smart healthcare devices for improving outcome from medical and wellness perspective.

Toney KM Lam, MBA

· Group CEO – Sramek Group Inc.
· Premium Member – American Heart Association
· Committee Director – HKFSCI
· Corporate Member – HKBMIA
· Member – HKMHDIA

Ir. Victor Ho

· Head of product in Geberit
· Product Manager in Nokia
· Project Manager in Fujikon
· Project Engineer in Rockapetta

Prof. Vellaisamy Roy

· Professor in City University of Hong Kong
· Professor in University of Glasgow
· Scientist in Intelligent System
· Inventor of medical micro fiber

Dr. Srinivas Bhylahalli

· CEO – Intellimed Healthcare
· Commercial Lead in SingHealth
· CEO Asia at Anatomics
· Cofounder – TriSail Medical

Prof. Tao Jun

· Principal of Cardiovascular in ZH in GZ
· Vice President of National Hypertension Center
· Medical Advisor in NMPA
· Scientist in GZ Bio-island Laboratory

Dr. Suvendra Das

· General Manager Asia – Philips Healthcare
· General Manager – HP India

Our strategic partners

We are global

Medical Paper Reference

Cardiac index assessment: Validation of a new
non-invasive very low current thoracic bioimpedance device by thermodilution

LINK

Hemodynamic monitoring using thoracic bioimpedance – an optimal solution for the treatment of hypertension

LINK

Sustained Cardiovascular Actions of APJ Agonism During Renin–Angiotensin System Activation and in Patients With Heart Failure

LINK

Hemodynamic differences among hypertensive patients with and without heart failure using impedance cardiography

LINK

Our story

The leading TEB (Thoracic Electrical Bioimpedance) technology was invented by Dr. Bo Sramek. It was confirmed by clinical studies to be a legitimate non-invasive counterpart for measurement of CO. NASA (National Aeronautics and Space Administration) appointed Dr. Bo Sramek as a principal investigator in 1985, to develop a device to monitor the heart performance of astronauts in space mission. The technology code name was NCCOM3.

Our story

In 1994, the NCCOM3 was enhanced in both accuracy and precision level and later re-packaged as BioZ. It was widely adopted by company like Cheertah, Philips Healthcare, Edward Lifescience and CAS Medical. They then developed their own hemodynamics devices in the Market.

Our story

In 1998, Dr. Bo Sramek further upgrade the outcome of BioZ and newly formed a company called Hemo Sapiens Inc. At the same time, the product was named as TEBCO (Hardware) and HOTMAN System (Software). HOTMAN System integrated with innovative data algorithms, which could clearly state the underlying causes of hypertension and recommended drug selection guide.

Our story

In 2018, Dr. Bo Sramek partnered with Mr. Toney Lam to form a new company “Sramek BioDynamics Inc.” to acquire all intellectual property of Hemo Sapiens Inc. and re-invented the HOTMAN System with cloud computing capability. With medical AI, HOTMAN system can predict and resolve the medical issues of hypertension in a highly effective and interactive ways.

Our story

In 2022, Mr. Toney Lam partnered with Professor Vellaisamy to form the company “Sramek Insight” with a mission to build a smart hemodynamics device for everyone, who can be easily to used at home, to monitor blood flow, blood pressure as well as to alert early stage of heart failure and stroke.

Message to us

To explore any potential opportunity with us

Room 626, 17W West Avenue,
Science Park, Shatin, N.T

info@sramekgroup.com